206 related articles for article (PubMed ID: 23672687)
41. Frequent methylation of RASSF1A in synovial sarcoma and the anti-tumor effects of 5-aza-2'-deoxycytidine against synovial sarcoma cell lines.
Numoto K; Yoshida A; Sugihara S; Kunisada T; Morimoto Y; Yoneda Y; Fujita Y; Nishida K; Ouchida M; Ozaki T
J Cancer Res Clin Oncol; 2010 Jan; 136(1):17-25. PubMed ID: 19578875
[TBL] [Abstract][Full Text] [Related]
42. Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures.
Cohen JR; Resnick DZ; Niewiadomski P; Dong H; Liau LM; Waschek JA
BMC Cancer; 2010 Dec; 10():676. PubMed ID: 21143927
[TBL] [Abstract][Full Text] [Related]
43. Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system.
Unland R; Kerl K; Schlosser S; Farwick N; Plagemann T; Lechtape B; Clifford SC; Kreth JH; Gerss J; Mühlisch J; Richter GH; Hasselblatt M; Frühwald MC
J Neurooncol; 2014 Jan; 116(2):237-49. PubMed ID: 24264533
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation.
Zhang ZY; Cai JJ; Hong J; Li KK; Ping Z; Wang Y; Ng HK; Yao Y; Mao Y
Med Oncol; 2016 Sep; 33(9):99. PubMed ID: 27449774
[TBL] [Abstract][Full Text] [Related]
45. Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2'-deoxycytidine in human breast cancer cells.
Tyagi T; Treas JN; Mahalingaiah PK; Singh KP
Breast Cancer Res Treat; 2015 Feb; 149(3):655-68. PubMed ID: 25663548
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways.
Moro H; Hattori N; Nakamura Y; Kimura K; Imai T; Maeda M; Yashiro M; Ushijima T
Gastric Cancer; 2020 Jan; 23(1):105-115. PubMed ID: 31555951
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-21 suppression impedes medulloblastoma cell migration.
Grunder E; D'Ambrosio R; Fiaschetti G; Abela L; Arcaro A; Zuzak T; Ohgaki H; Lv SQ; Shalaby T; Grotzer M
Eur J Cancer; 2011 Nov; 47(16):2479-90. PubMed ID: 21775132
[TBL] [Abstract][Full Text] [Related]
48. Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells.
Bovenzi V; Momparler RL
Cancer Chemother Pharmacol; 2001 Jul; 48(1):71-6. PubMed ID: 11488527
[TBL] [Abstract][Full Text] [Related]
49. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma.
Gordon RE; Zhang L; Peri S; Kuo YM; Du F; Egleston BL; Ng JMY; Andrews AJ; Astsaturov I; Curran T; Yang ZJ
Clin Cancer Res; 2018 Mar; 24(6):1375-1388. PubMed ID: 29437795
[No Abstract] [Full Text] [Related]
50. Analysis of the antiproliferative effects of 3-deazaneoplanocin A in combination with standard anticancer agents in rhabdoid tumor cell lines.
Unland R; Borchardt C; Clemens D; Kool M; Dirksen U; Frühwald MC
Anticancer Drugs; 2015 Mar; 26(3):301-11. PubMed ID: 25415657
[TBL] [Abstract][Full Text] [Related]
51. 13-Cis Retinoic Acid Induces Neuronal Differentiation in Daoy (Medulloblastoma) Cells Through Epigenetic Regulation of Topoisomerase IIβ.
Chen J; Zhang JX; Lei HX; Li XY; Yan YX; Wang YL; Lv YH; Yan YL; Lei YH
Appl Biochem Biotechnol; 2023 Dec; 195(12):7429-7445. PubMed ID: 37000354
[TBL] [Abstract][Full Text] [Related]
52. Epigenetic modulators combination with chemotherapy in breast cancer cells.
Ari F; Napieralski R; Akgun O; Magdolen V; Ulukaya E
Cell Biochem Funct; 2021 Jun; 39(4):571-583. PubMed ID: 33608886
[TBL] [Abstract][Full Text] [Related]
53. The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment.
Patties I; Kallendrusch S; Böhme L; Kendzia E; Oppermann H; Gaunitz F; Kortmann RD; Glasow A
J Exp Clin Cancer Res; 2019 Oct; 38(1):420. PubMed ID: 31639020
[TBL] [Abstract][Full Text] [Related]
54. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells.
Yu LJ; Wu ML; Li H; Chen XY; Wang Q; Sun Y; Kong QY; Liu J
Neoplasia; 2008 Jul; 10(7):736-44. PubMed ID: 18592012
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic modifiers 5-aza-2'-deoxycytidine and valproic acid differentially change viability, DNA damage and gene expression in metastatic and non-metastatic colon cancer cell lines.
Ghecham A; Senator A; Pawlowska E; Bouafia W; Błasiak J
Acta Biochim Pol; 2019 Jul; 66(3):355-360. PubMed ID: 31284710
[TBL] [Abstract][Full Text] [Related]
57. miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma.
Shi J; Yang L; Wang T; Zhang J; Guo X; Huo X; Niu H
Mol Med Rep; 2013 Oct; 8(4):1111-7. PubMed ID: 23970061
[TBL] [Abstract][Full Text] [Related]
58. Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy.
Takeshima H; Wakabayashi M; Hattori N; Yamashita S; Ushijima T
Carcinogenesis; 2015 Feb; 36(2):192-201. PubMed ID: 25477340
[TBL] [Abstract][Full Text] [Related]
59. Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
Eslin D; Lee C; Sankpal UT; Maliakal P; Sutphin RM; Abraham L; Basha R
Tumour Biol; 2013 Oct; 34(5):2781-9. PubMed ID: 23686785
[TBL] [Abstract][Full Text] [Related]
60. The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma.
Kumar A; Fillmore HL; Kadian R; Broaddus WC; Tye GW; Van Meter TE
Mol Cancer Res; 2009 Nov; 7(11):1813-21. PubMed ID: 19887560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
